Purpose-built for physicians Cases of acute cholecystitis linked to GLP-1 receptor agonist use in US Researchers have found 36 cases of acute cholecystitis associated with the use of GLP-1 receptor agonists in the U.S., according to findings from the FDA Adverse Event Reporting System published in JAMA Internal Medicine
Failure to Warn Allegations Lawsuits against Novo Nordisk and Eli Lilly are built on allegations that both pharmaceutical companies failed to properly warn consumers about the health risks tied to their GLP-1 drugs
Ive been it mouth and lost 12 pounds
Retatrutide: Phase 2 Trial The Phase 2 trial enrolled 338 adults with obesity
Starter plans typically cover lower doses appropriate for the initial titration period
Saunders, MD, DABOM, an obesity physician at Weill Cornell Medicine, says GLP-1s have proven to be nothing short of a miracle for patients with obesity and sleep apnea. Since it generally requires more weight loss to improve OSA compared to other weight-related health complications, GLP-1s are complete game-changers for patients with both conditions, according to Saunders
